搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
1 天
I want to add these 2 FTSE gems to my Stocks and Shares ISA
This Fool wants to make the most of the benefits a Stocks and Shares ISA provides. He's keen on these two stocks.
Knowridge
1 天
Common heartburn drugs linked to increased kidney disease risk
Proton pump inhibitors (PPIs), including well-known brands like Prilosec, Nexium, and Prevacid, are some of the most commonly ...
2 天
GlaxoSmithKline Sell Rating Justified by Earnings Concerns and Market Challenges
Bank of America Securities analyst Graham Parry maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) yesterday and set a ...
2 天
Another Mistrial in Zantac: Fourth Illinois Jury Fails to Award Damages
On Wednesday, a jury in Cook County Circuit Court in Illinois ended in a mistrial in a case against Zantac manufacturer ...
Acsh.org
2 天
On the Toxic Tort Docket
Recent surprise decisions have upended plaintiffs’ expectations on the toxic tort front. In Delaware, the top court is ...
2 天
Boehringer, GSK, Pfizer Still Face Zantac Cases Despite Mistrial
An Illinois mistrial involving the recalled medication Zantac is the latest court decision involving the recalled drug, but ...
Becker's Hospital Review
2 天
Zantac cancer trial results in hung jury
A Chicago jury failed to reach a verdict Sept. 18 over claims that heartburn drug Zantac causes cancer, Reuters exclusively reported.
devdiscourse
2 天
Hung Jury in Latest Zantac Cancer Trial
The recent trial regarding the discontinued heartburn drug Zantac, which allegedly causes cancer, ended in a hung jury. The ...
California Healthline
2 天
California Healthline Daily Edition
Below, check out the roundup of California Healthline’s coverage. For today's national health news, read KFF Health News’ Morning Briefing.
2 天
Boehringer Ingelheim faces second hung jury in Chicago Zantac trial
The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, ...
kffhealthnews
2 天
Neuralink ‘Blindsight’ Brain Implant Gets FDA ‘Breakthrough Device’ Nod
The device is a variant of Neuralink's brain implant technology, in this case designed to "enable even those who have lost both eyes" to see, according to owner Elon Musk. Separately, progress is ...
3 天
Zantac诉讼案在芝加哥再次出现陪审团僵局
第二起关于已停产的胃灼热药物Zantac致癌指控的审判今天在芝加哥以陪审团僵局结束。陪审团无法就勃林格殷格翰公司对一名伊利诺伊州男子索赔的责任达成一致决定。原告Ronald Kimbrow声称,他从1995年到2019年使用Zantac导致了前列腺癌的发展。 代表Kimbrow的Eric Olson对陪审团的审议表示感谢,并指出这是勃林格殷格翰第二次未能说服陪审团Zantac是安全的。他确认该案将 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈